RTX's Raytheon Unit Set to See Sales Boost With Major Defense Contracts

RTX Corporation's Raytheon unit reported sales increases of 1.4% in 2024 and 4.7% in 2023, bolstered by significant contract wins including a $1.10 billion AIM-9X deal and a $1 billion SM-3 contract. This robust contract flow mirrors a broader industry trend of global defense modernization, with peers like Lockheed Martin and Northrop Grumman also securing substantial new business. While RTX shares have outperformed, gaining 45.3% over the past year and trading at a relative valuation discount, analyst earnings estimates for 2025 and 2026 have recently declined, resulting in a Zacks Rank #4 (Sell) for the stock.

Analysis

RTX Corporation is exhibiting a clear divergence between strong current operational performance and deteriorating forward-looking analyst sentiment. The company's Raytheon defense segment continues to secure substantial contracts, including a $1.10 billion deal for AIM-9X missiles and a $1 billion contract for SM-3 missiles, which support its recent top-line growth of 1.4% in 2024 and 4.7% in 2023. This momentum is reflected in the stock's 45.3% gain over the past year, significantly outperforming the industry's 19% growth. Furthermore, RTX shares trade at a relative discount with a forward P/E of 22.95X compared to the industry average of 26.70X. However, these positive factors are directly contradicted by a recent southward revision in the Zacks Consensus Estimate for 2025 and 2026 earnings, culminating in a Zacks Rank #4 (Sell). This negative outlook emerges despite a robust industry backdrop where peers like Lockheed Martin and Northrop Grumman are also winning major contracts, indicating strong secular demand from global defense modernization.

Key Decisions for Investors

• Investors must weigh RTX's strong contract pipeline and recent share price outperformance against the material risk indicated by declining forward earnings estimates and a formal 'Sell' rating.
• While the stock's valuation appears discounted relative to the industry, the negative revisions to future earnings suggest this discount may be warranted and could signal potential for near-term underperformance.
• It is critical to monitor upcoming quarterly reports for any management guidance that could reverse the negative trend in analyst estimates, as the full financial impact of recent large contract wins may not yet be reflected in consensus.
• Given the positive sentiment and strong contract flow for peers like Lockheed Martin and Northrop Grumman, investors seeking exposure to the defense sector could consider these alternatives which currently lack the headwind of downward earnings revisions seen with RTX.